Work

Long-Term Treatment with Pacritinib on a Compassionate Use Basis in Patients with Advanced Myelofibrosis

Year: 2021

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2021-148793

Authors: Claire N. Harrison, Abdulraheem Yacoub, Bart L. Scott, Adam J. Mead, Aaron T. Gerds, Jean-Jacques Kiladjian, Ruben A. Mesa, Miklos Egyed, Christof Scheid, Valentín Garcia Gutierrez, Sarah A Buckley, Kris Kanellopoulos, John Mascarenhas

Institutions: Guy's and St Thomas' NHS Foundation Trust, The University of Kansas Cancer Center, Fred Hutch Cancer Center, University of Oxford, Cleveland Clinic, Inserm, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, Mays Cancer Center at UT Health San Antonio, Somogy Megyei Kaposi Mór Oktató Kórház, University of Cologne, Hospital Universitario Ramón y Cajal, CTI BioPharma (United States), Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3214117282

Cites:

Cited by:

Related to: 10